These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12745506)

  • 21. Depression following smoking cessation in women.
    Bock BC; Goldstein MG; Marcus BH
    J Subst Abuse; 1996; 8(1):137-44. PubMed ID: 8743774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electronic nicotine devices to aid smoking cessation by alcohol- and drug-dependent clients: protocol for a pilot randomised controlled trial.
    Guillaumier A; Manning V; Wynne O; Gartner C; Borland R; Baker AL; Segan CJ; Skelton E; Moore L; Bathish R; Lubman DI; Bonevski B
    Trials; 2018 Aug; 19(1):415. PubMed ID: 30071863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
    Dalack GW; Becks L; Hill E; Pomerleau OF; Meador-Woodruff JH
    Neuropsychopharmacology; 1999 Aug; 21(2):195-202. PubMed ID: 10432467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-cessation depressive mood predicts failure to quit smoking: the role of coping and personality traits.
    Berlin I; Covey LS
    Addiction; 2006 Dec; 101(12):1814-21. PubMed ID: 17156181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence to treatment to help quit smoking: effects of task performance and coping with withdrawal symptoms.
    López-Torrecillas F; Rueda MM; López-Quirantes EM; Santiago JM; Tapioles RR
    BMC Public Health; 2014 Nov; 14():1217. PubMed ID: 25424314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
    Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subjective social status affects smoking abstinence during acute withdrawal through affective mediators.
    Reitzel LR; Mazas CA; Cofta-Woerpel L; Li Y; Cao Y; Businelle MS; Cinciripini PM; Wetter DW
    Addiction; 2010 May; 105(5):928-36. PubMed ID: 20219054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of short-term success in smoking cessation in relation to attendance at a smoking cessation program.
    Dorner TE; Tröstl A; Womastek I; Groman E
    Nicotine Tob Res; 2011 Nov; 13(11):1068-75. PubMed ID: 21832273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of Smoking Abstinence in Women Living With Human Immunodeficiency Virus Infection.
    Kim SS; Cooley ME; Lee SA; DeMarco RF
    Nurs Res; 2020; 69(3):167-175. PubMed ID: 31977840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time-varying smoking abstinence predicts lower depressive symptoms following smoking cessation treatment.
    Kahler CW; Spillane NS; Busch AM; Leventhal AM
    Nicotine Tob Res; 2011 Feb; 13(2):146-50. PubMed ID: 21106663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotine dependence, depression, and gender: characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain.
    Pomerleau OF; Pomerleau CS; Mehringer AM; Snedecor SM; Ninowski R; Sen A
    Nicotine Tob Res; 2005 Feb; 7(1):91-102. PubMed ID: 15804681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nicotine patch in smoking cessation. A randomized trial with telephone counseling.
    Westman EC; Levin ED; Rose JE
    Arch Intern Med; 1993 Aug; 153(16):1917-23. PubMed ID: 8250653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of anxiety sensitivity in relation to nicotine withdrawal symptoms during smoking cessation: an examination among successful quitters.
    Bakhshaie J; Zvolensky MJ; Langdon KJ; Leventhal AM; Schmidt NB
    Cogn Behav Ther; 2018 Jul; 47(4):301-314. PubMed ID: 29130427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal clonidine reduced some withdrawal symptoms but did not increase smoking cessation.
    Prochazka AV; Petty TL; Nett L; Silvers GW; Sachs DP; Rennard SI; Daughton DM; Grimm RH; Heim C
    Arch Intern Med; 1992 Oct; 152(10):2065-9. PubMed ID: 1417380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking behavior on the first day of a quit attempt predicts long-term abstinence.
    Westman EC; Behm FM; Simel DL; Rose JE
    Arch Intern Med; 1997 Feb; 157(3):335-40. PubMed ID: 9040302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise and Counseling for Smoking Cessation in Smokers With Depressive Symptoms: A Randomized Controlled Pilot Trial.
    Bernard P; Ninot G; Cyprien F; Courtet P; Guillaume S; Georgescu V; Picot MC; Taylor A; Quantin X
    J Dual Diagn; 2015; 11(3-4):205-16. PubMed ID: 26683252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression.
    Thorsteinsson HS; Gillin JC; Patten CA; Golshan S; Sutton LD; Drummond S; Clark CP; Kelsoe J; Rapaport M
    Neuropsychopharmacology; 2001 Apr; 24(4):350-8. PubMed ID: 11182530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supervised, Vigorous Intensity Exercise Intervention for Depressed Female Smokers: A Pilot Study.
    Patten CA; Bronars CA; Vickers Douglas KS; Ussher MH; Levine JA; Tye SJ; Hughes CA; Brockman TA; Decker PA; DeJesus RS; Williams MD; Olson TP; Clark MM; Dieterich AM
    Nicotine Tob Res; 2017 Jan; 19(1):77-86. PubMed ID: 27613946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy.
    Shiffman S; Ferguson SG; Gwaltney CJ; Balabanis MH; Shadel WG
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):637-44. PubMed ID: 16261317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nicotine withdrawal in smokers with current depressive disorders undergoing intensive smoking cessation treatment.
    Blalock JA; Robinson JD; Wetter DW; Schreindorfer LS; Cinciripini PM
    Psychol Addict Behav; 2008 Mar; 22(1):122-8. PubMed ID: 18298238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.